Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edo Vellenga

Showing results (31-40 of 246) with videos related to

Pageof 25
Sort By:
Journal of Hematotherapy & Stem Cell Research|August 20, 2002
Peripheral blood stem cells differ from bone marrow stem cells in cell cycle status, repopulating potential, and sensitivity toward hyperthermic purging in mice mobilized with cyclophosphamide and granulocyte colony-stimulating factorPieter K Wierenga, Rita Setroikromo, Gera Kamps, et al.
Hereditary Cancer in Clinical Practice|September 4, 2009
Familial multiple myeloma: report on two families and discussion of screening optionsErica H Gerkes, Mirjam M de Jong, Rolf H Sijmons, et al.
Experimental Hematology|May 24, 2003
Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathwayAlbertus T J Wierenga, Irma Vogelzang, Bart J L Eggen, et al.
Leukemia Research|November 22, 2002
Proteolytic degradation of Smad4 in extracts of AML blastsAlbertus T J Wierenga, Bart J L Eggen, Wiebe Kruijer, et al.
Clinical Nuclear Medicine|September 8, 2012
Is FDG PET a better imaging tool than somatostatin receptor scintigraphy in patients with relapsing multiple myeloma?Esther G M de Waal, Riemer H J A Slart, Edo Vellenga
Experimental Hematology|June 21, 2005
Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathwayHein Schepers, Albertus T J Wierenga, Bart J L Eggen, et al.
Blood|December 25, 2007
Long-term maintenance of human hematopoietic stem/progenitor cells by expression of BMI1Aleksandra Rizo, Bert Dontje, Edo Vellenga, et al.
Haematologica|June 19, 2009
Mammalian target of rapamycin activity is required for expansion of CD34+ hematopoietic progenitor cellsChristian R Geest, Fried J Zwartkruis, Edo Vellenga, et al.
British Journal of Haematology|October 9, 2003
Predictive value of early 18F-fluoro-deoxyglucose positron emission tomography in chemosensitive relapsed lymphomaBart Schot, Gustaaf van Imhoff, Jan Pruim, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2009
Improved survival among younger but not among older patients with Multiple Myeloma in the Netherlands, a population-based study since 1989Michael Schaapveld, Otto Visser, Sabine Siesling, et al.
Pageof 25

Showing results (31-40 of 246) with videos related to

Sort By:
Pageof 25
Journal of Hematotherapy & Stem Cell Research|August 20, 2002
Peripheral blood stem cells differ from bone marrow stem cells in cell cycle status, repopulating potential, and sensitivity toward hyperthermic purging in mice mobilized with cyclophosphamide and granulocyte colony-stimulating factorPieter K Wierenga, Rita Setroikromo, Gera Kamps, et al.
Hereditary Cancer in Clinical Practice|September 4, 2009
Familial multiple myeloma: report on two families and discussion of screening optionsErica H Gerkes, Mirjam M de Jong, Rolf H Sijmons, et al.
Experimental Hematology|May 24, 2003
Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathwayAlbertus T J Wierenga, Irma Vogelzang, Bart J L Eggen, et al.
Leukemia Research|November 22, 2002
Proteolytic degradation of Smad4 in extracts of AML blastsAlbertus T J Wierenga, Bart J L Eggen, Wiebe Kruijer, et al.
Clinical Nuclear Medicine|September 8, 2012
Is FDG PET a better imaging tool than somatostatin receptor scintigraphy in patients with relapsing multiple myeloma?Esther G M de Waal, Riemer H J A Slart, Edo Vellenga
Experimental Hematology|June 21, 2005
Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathwayHein Schepers, Albertus T J Wierenga, Bart J L Eggen, et al.
Blood|December 25, 2007
Long-term maintenance of human hematopoietic stem/progenitor cells by expression of BMI1Aleksandra Rizo, Bert Dontje, Edo Vellenga, et al.
Haematologica|June 19, 2009
Mammalian target of rapamycin activity is required for expansion of CD34+ hematopoietic progenitor cellsChristian R Geest, Fried J Zwartkruis, Edo Vellenga, et al.
British Journal of Haematology|October 9, 2003
Predictive value of early 18F-fluoro-deoxyglucose positron emission tomography in chemosensitive relapsed lymphomaBart Schot, Gustaaf van Imhoff, Jan Pruim, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2009
Improved survival among younger but not among older patients with Multiple Myeloma in the Netherlands, a population-based study since 1989Michael Schaapveld, Otto Visser, Sabine Siesling, et al.
Pageof 25